List of works - Jacobus J Bosch

A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice

scientific article published in September 2015

A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans

scientific article published on 01 April 2006

Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy.

scientific article published in March 2004

Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines

scientific article published on August 2015

Immunotherapy of Uveal Melanoma ⬇️

scientific article published on October 21, 2011

Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13.

scientific article published on 24 July 2017

Inflammatory aneurysm of the common iliac artery mimicking appendicitis.

scientific article published in March 2008

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

scientific article published on 6 March 2008

MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.

scientific article

Monitoring dynamic interactions of tumor cells with tissue and immune cells in a lab-on-a-chip.

scientific article published on 20 November 2013

New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself

scientific article published on 15 May 2017

Novel Adjuvant Therapy for Ocular Melanoma

scientific article published on 15 May 2017

Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva

scientific article published on 11 August 2011

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.

scientific article published on 28 August 2007

Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80 ⬇️

scientific article published on May 9, 2011

Tumor-associated lymphangiogenesis in the development of conjunctival melanoma

scientific article published on 09 September 2011

Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.